about
Serine/threonine kinase 17A is a novel p53 target gene and modulator of cisplatin toxicity and reactive oxygen species in testicular cancer cellsTumor suppressors: enhancers or suppressors of regeneration?Insulin-like Growth Factor 1 Signaling Axis Meets p53 Genome Protection PathwaysMutant p53 Drives Cancer by Subverting Multiple Tumor Suppression PathwaysAntioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal ResultsPathophysiological mechanisms of death resistance in colorectal carcinomaSmall molecule compounds targeting the p53 pathway: are we finally making progress?p53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening systemVariations in Glycogen Synthesis in Human Pluripotent Stem Cells with Altered Pluripotent StatesMethyl jasmonate: putative mechanisms of action on cancer cells cycle, metabolism, and apoptosisChemical metabolic inhibitors for the treatment of blood-borne cancersThe complex landscape of pancreatic cancer metabolismAlternative fuel--another role for p53 in the regulation of metabolism.Increased oxidative metabolism in the Li-Fraumeni syndromeMetabolic sensing by p53: keeping the balance between life and deathp53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation.p53 Research: the past thirty years and the next thirty years.Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport.The biology of lysine acetylation integrates transcriptional programming and metabolismThe Ribosomal Protein-Mdm2-p53 Pathway and Energy Metabolism: Bridging the Gap between Feast and Famine.Impact of the adenoviral E4 Orf3 protein on the activity and posttranslational modification of p53.Tumor suppressor p53 regulates bile acid homeostasis via small heterodimer partner.Increase developmental plasticity of human keratinocytes with gene suppressionMechanism of Cisplatin-Induced Cytotoxicity Is Correlated to Impaired Metabolism Due to Mitochondrial ROS Generation.Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils.REDOX IMAGING OF THE p53-DEPENDENT MITOCHONDRIAL REDOX STATE IN COLON CANCER EX VIVOThe proline regulatory axis and cancerN-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy.The p53 family member p73 modulates the proproliferative role of IGFBP3 in short children born small for gestational agep63 supports aerobic respiration through hexokinase II.p53 and rapamycin are additive.Metabolic regulation of oxygen and redox homeostasis by p53: lessons from evolutionary biology?TAp73 depletion accelerates aging through metabolic dysregulationThe presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolismp53 attenuates AKT signaling by modulating membrane phospholipid compositionPhospho-ΔNp63α/SREBF1 protein interactions: bridging cell metabolism and cisplatin chemoresistanceTwist promotes reprogramming of glucose metabolism in breast cancer cells through PI3K/AKT and p53 signaling pathways.Roles of microRNA on cancer cell metabolism.Relevant Networks involving the p53 Signalling Pathway in Renal Cell Carcinoma.Pharmacological activation of p53 in cancer cells
P2860
Q24299676-51BE767D-A83A-4A44-AF4D-EDA42EB97C66Q24618747-F9B20835-887B-4191-AB87-FE84E6C8DE79Q26742114-795F6552-65BB-46A3-BDC8-BB7F60A5DE22Q26767396-30E71F97-D668-45E2-A78A-A2AA60527628Q26774897-1A2C8475-78B5-4516-9AEA-34CACF54E7BEQ26778007-D973BDF4-8F38-43C1-B5D5-DB5076BD59E3Q27027835-F650F595-B62C-47A4-823F-46EF72C02A8EQ28478414-C610E134-A9DA-4764-B4C3-532398AB0400Q28550951-4B7762A1-44BE-4F2F-9141-95D1C26E7E16Q28658683-01CEB091-A88F-448C-80B8-EF7F97426C97Q28822335-00003C73-8732-4EBB-836D-EB71E9804AF6Q33827703-49EDCCAE-7177-436F-952F-80577D722C95Q33841854-2A9BC0A0-3228-4B69-AE32-2821BC2856EDQ34008143-2134F2DE-4E29-4EA0-83A5-86942940E5C6Q34068127-16B74F47-766F-42D5-B982-012BDF0FFDF1Q34276678-2F7A31D4-3327-4EDB-AA98-BBE56FE1C1ADQ34313764-BD07C0A7-823E-4CF7-A6B1-97B062EBCDC0Q34646307-8DC59E8F-10FD-4F8C-805B-176DC5B690BAQ34692752-937FABD9-D04A-4EEB-B27F-AED3CD4F8D9CQ35103161-97BBC61E-6BD1-4698-9874-4741A2DD35ABQ35111076-5F224045-73B9-41B3-B3C9-8E8D34F14173Q35134152-AE6B6114-32E1-45E3-81F0-0FF1025B7891Q35149576-E0F3CB6F-61D3-4D06-A78A-0F3C56B7B6E0Q35738714-893D45EC-B99C-447C-BC75-BA7C994010A9Q35795073-52F4C986-A697-42DE-885F-54B99BBC7257Q35869874-7BFD155B-20FC-49BB-9188-5A7913919537Q36050265-78AA7635-9F5E-411B-8576-4A027F862E89Q36055168-20C9EE4E-E557-402B-9ADA-410DF82D447FQ36063747-162486A1-73C8-485B-B51B-401C30A6AD58Q36078959-E59F4A6F-8A93-4904-B2AF-97D1E415E3F0Q36140629-DBEC665F-6D68-4754-8B21-A3343F108102Q36239686-ED9D7132-52A1-4EF9-A6CD-1D8944510A87Q36240893-D064B178-75A4-43AB-A06E-19EC8BAADE07Q36326369-8E8ECA98-3E87-48EF-98EC-D4D9B6B0977FQ36356298-F614FEE1-B083-4FD0-B7E8-B6C655EC64DBQ36392145-FC3E082B-7A2F-41E7-BA6D-F614F2F8C544Q36413285-9D416542-F9CB-4571-A09B-1EE52B0EAC82Q36585153-6BB11979-FEC8-4DD7-9F08-6420C9072C68Q36735719-7704F131-3BD3-488E-8A0C-4EC535FECAA1Q37191174-224C3A13-5240-4A7B-8713-9F0F71AE900F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
p53 regulation of metabolic pathways.
@en
p53 regulation of metabolic pathways.
@nl
type
label
p53 regulation of metabolic pathways.
@en
p53 regulation of metabolic pathways.
@nl
prefLabel
p53 regulation of metabolic pathways.
@en
p53 regulation of metabolic pathways.
@nl
P2860
P1476
p53 regulation of metabolic pathways.
@en
P2093
Karen H Vousden
P2860
P304
P356
10.1101/CSHPERSPECT.A001040
P577
2009-12-02T00:00:00Z